Xenogen-free media provide variable equine mesenchymal stromal cell expansion after a 7-day culture period
American Journal of Veterinary Research · 2025
DOI: 10.2460/ajvr.25.03.0109 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Maureen K Larson und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Cell Culture Techniques, Culture Media. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To determine the xenogen-free serum source that provides the greatest number of live equine mesenchymal stromal cells (MSCs) while maintaining the MSC phenotype.
Methods
Equine bone marrow–derived MSCs from 8 horses were cultured for 7 days in media containing one of the following serum treatments: 10% xenogeneic serum, 10% or 20% commercial allogeneic equine serum, 10% autologous serum, 10% equine pooled platelet lysate (PPL), or a staged media reduction of xenogeneic media. Live cell numbers, MSC viability, and MSC immunophenotype were compared.
Results
The use of 10% commercial allogeneic equine serum in media resulted in a significant decrease in live MSC count compared to xenogeneic serum ( P = .01; 95% CI, −244,766 to −48,038). Autologous serum, staged reduction, and PPL had no significant difference in live MSC number collected at day 7 as compared to xenogeneic serum. There were no significant differences in cell count due to the horse’s age group. Viability was significantly greater using PPL than all other xenogen-free serums across the < 10-year and ≥ 10-year age groups. Mesenchymal stromal cells from all treatments were high in CD44, CD90, and major histocompatibility complex (MHC) I expression and low in CD45 and MHC II expression. Significant differences in CD44, CD45, CD90, MHC I, and MHC II expression levels were seen across treatment and age analysis.
Conclusions
The use of PPL for MSC media in the final 7 days of culture allows for adequate expansion and viability of MSCs and maintenance of MSC immunophenotypic markers. Clinical Relevance MSCs can be cultured in nonxenogeneic media for 7 days prior to harvest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
ORCID-Profile: J Lacy Kamm
Zitieren
APA
Larson, M. K., Gaffney, C., Hoagland, C., Jayawickrama, J., & Kamm, J. L. (2025). Xenogen-free media provide variable equine mesenchymal stromal cell expansion after a 7-day culture period. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.03.0109
Vancouver
Larson MK, Gaffney C, Hoagland C, Jayawickrama J, Kamm JL. Xenogen-free media provide variable equine mesenchymal stromal cell expansion after a 7-day culture period. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.25.03.0109
BibTeX
@article{Larson2025,
author = {Larson, Maureen K and Gaffney, Caitlin and Hoagland, Cherise and Jayawickrama, Judith and Kamm, J Lacy},
title = {Xenogen-free media provide variable equine mesenchymal stromal cell expansion after a 7-day culture period},
journal = {American Journal of Veterinary Research},
year = {2025},
doi = {10.2460/ajvr.25.03.0109}
}
EUVIMED